{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "mesh:D009362",
      "entity_text" : "metastasis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01901",
      "entity_text" : "NPs-alphaIL6R Ab-CD44",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Most importantly, we provided the in vivo evidence showing that the NPs-alphaIL6R Ab-CD44 treatment impeded the metastasis of breast cancer in both the 4T1-xenograft mouse model and MMTV-PyMT model through down-regulating the production of cytokines or enzymes such as VEGFA and MMP-9 as well as inhibiting the angiogenesis.",
  "reading_complete" : "2020-08-03T10:57:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:56:24Z",
  "trigger" : "impeded",
  "evidence" : [ "NPs-alphaIL6R Ab-CD44 treatment impeded the metastasis" ],
  "pmc_id" : "5327649",
  "score" : 0
}